# A Pilot Study of MabThera (Rituximab) Evaluated by MRI in Patients With Rheumatoid Arthritis.

> **NCT00502853** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 10 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** rituximab [MabThera/Rituxan]
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT00502853
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10-25
- **Primary completion:** 2010-07-23
- **Final completion:** 2010-07-23
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00502853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00502853, "A Pilot Study of MabThera (Rituximab) Evaluated by MRI in Patients With Rheumatoid Arthritis.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00502853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*